MEBIPHAR AUSTRAPHARM PHARMACEUTICAL JOINT VENTURE

Business Nature: Manufacturer (Factory)

Company Profile:

MEBIPHAR AUSTRAPHARM is a prominent pharmaceutical joint venture based in Vietnam, established through the collaboration between Mebiphar (Central Pharmaceutical Joint Stock Company) and Austrapharm. The company operates as a specialized pharmaceutical manufacturer, equipped with modern production facilities that comply with GMP-WHO standards. Its primary business scope includes the research, development, production, and distribution of a wide range of pharmaceutical products, including prescription drugs, over-the-counter medications, and health supplements. By integrating advanced international technology with local expertise, the company focuses on providing high-quality, affordable healthcare solutions for the Vietnamese market and beyond.

MEBIPHAR AUSTRAPHARM PHARMACEUTICAL JOINT VENTURE manufactures or sells a diverse range of pharmaceutical products. These commonly include:

Antibiotics such as Amoxicillin, Cefalexin, and Azithromycin.

Analgesics and antipyretics like Paracetamol and Ibuprofen.

Anti-inflammatory drugs including Dexamethasone and Prednisolone.

Vitamins and mineral supplements, such as Multivitamins, Vitamin C, and Calcium preparations.

Gastrointestinal medications like Omeprazole.

Antihistamines, for example Loratadine.

Cough and cold remedies, including expectorants and antitussives.

Dermatological preparations such as creams and ointments.

Eye drops and nasal drops.

Antacids.

Antifungals.

Anthelmintics.

B-complex vitamins.